ATE205719T1 - Reinigung von plasmaproteinen - Google Patents

Reinigung von plasmaproteinen

Info

Publication number
ATE205719T1
ATE205719T1 AT94915731T AT94915731T ATE205719T1 AT E205719 T1 ATE205719 T1 AT E205719T1 AT 94915731 T AT94915731 T AT 94915731T AT 94915731 T AT94915731 T AT 94915731T AT E205719 T1 ATE205719 T1 AT E205719T1
Authority
AT
Austria
Prior art keywords
pct
aqueous phase
detergent
sec
salt
Prior art date
Application number
AT94915731T
Other languages
English (en)
Inventor
Sven Isaksson
Stefan Winge
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Application granted granted Critical
Publication of ATE205719T1 publication Critical patent/ATE205719T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/79Transferrins, e.g. lactoferrins, ovotransferrins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/30Extraction; Separation; Purification by precipitation
    • C07K1/303Extraction; Separation; Purification by precipitation by salting out
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76Albumins
    • C07K14/765Serum albumin, e.g. HSA
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81Protease inhibitors
    • C07K14/8107Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121Serpins
    • C07K14/8125Alpha-1-antitrypsin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Analytical Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Treatments Of Macromolecular Shaped Articles (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
AT94915731T 1993-05-07 1994-05-06 Reinigung von plasmaproteinen ATE205719T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE19939301582A SE9301582D0 (sv) 1993-05-07 1993-05-07 Purification of plasma proteins
PCT/SE1994/000422 WO1994026287A1 (en) 1993-05-07 1994-05-06 Purification of plasma proteins

Publications (1)

Publication Number Publication Date
ATE205719T1 true ATE205719T1 (de) 2001-10-15

Family

ID=20389869

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94915731T ATE205719T1 (de) 1993-05-07 1994-05-06 Reinigung von plasmaproteinen

Country Status (15)

Country Link
US (1) US5817765A (de)
EP (1) EP0700300B1 (de)
JP (1) JP3771935B2 (de)
AT (1) ATE205719T1 (de)
AU (1) AU677332B2 (de)
CA (1) CA2161804C (de)
DE (1) DE69428356T2 (de)
DK (1) DK0700300T3 (de)
ES (1) ES2164702T3 (de)
FI (1) FI113779B (de)
NO (1) NO313084B1 (de)
NZ (1) NZ266234A (de)
PT (1) PT700300E (de)
SE (1) SE9301582D0 (de)
WO (1) WO1994026287A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9500724D0 (sv) 1994-06-23 1995-02-24 Pharmacia Ab Filtrering
ES2099678B1 (es) * 1995-11-03 1998-02-16 Grifols Grupo Sa Procedimiento para la inactivacion de virus en proteinas.
SE9902388D0 (sv) * 1999-06-23 1999-06-23 Pharmacia & Upjohn Ab Method for purification of proteins
US6518406B1 (en) 1999-06-23 2003-02-11 Octapharma Ag Method for purification of proteins
DE19932782A1 (de) * 1999-07-14 2001-01-18 Biotest Pharma Gmbh Verfahren zur chromatographischen Fraktionierung von Plasma oder Serum, so erhaltene Präparate und deren Verwendung
KR20020063597A (ko) * 1999-12-20 2002-08-03 미츠비시 웰파마 가부시키가이샤 다공성막으로 처리되어 바이러스가 제거된 혈장 단백질조성물 및 그 제조 방법
CA2534900A1 (en) * 2003-08-12 2005-02-17 Octapharma Ag Process for preparing an alpha-1-antitrypsin solution
CA2572327A1 (en) * 2004-06-29 2006-02-02 Reliance Life Sciences Pvt. Ltd. Process for the preparation of virus-safe biological fluids
AU2005229674B2 (en) * 2004-11-18 2010-11-04 Kedrion Melville Inc. Low concentration solvent/detergent process of immuneglobulin with pre-treatment
WO2010033913A1 (en) * 2008-09-22 2010-03-25 Icb International, Inc. Antibodies, analogs and uses thereof
US20100136584A1 (en) * 2008-09-22 2010-06-03 Icb International, Inc. Methods for using antibodies and analogs thereof
CA2742817A1 (en) 2008-11-20 2010-05-27 Biogen Idec Ma Inc. Arginine inactivation of viruses
CN102812118B (zh) * 2010-04-08 2016-01-20 恰根有限公司 分离和纯化核酸的方法
EP2395082A1 (de) 2010-06-14 2011-12-14 QIAGEN GmbH Extraktion von Nukleinsäuren aus in Wachs eingebetteten Proben
US8921062B2 (en) 2010-11-09 2014-12-30 Quest Diagnostics Investments Incorporated Diagnostic and prognostic assays based on circulating tyrosine kinase activity
US10112987B2 (en) 2012-01-09 2018-10-30 Icb International, Inc. Blood-brain barrier permeable peptide compositions comprising a vab domain of a camelid single domain heavy chain antibody against an amyloid-beta peptide
US10112988B2 (en) 2012-01-09 2018-10-30 Icb International, Inc. Methods of assessing amyloid-beta peptides in the central nervous system by blood-brain barrier permeable peptide compositions comprising a vab domain of a camelid single domain heavy chain antibody against an anti-amyloid-beta peptide
US9534029B2 (en) 2012-10-03 2017-01-03 Csl Behring Ag Method of purifying proteins
WO2014055552A1 (en) * 2012-10-03 2014-04-10 Csl Behring Llc A method of purifying proteins
US10836790B1 (en) * 2019-09-20 2020-11-17 Plasma Technologies, Llc Therapeutic protein compositions and methods
US10815270B1 (en) * 2019-09-20 2020-10-27 Plasma Technologies, Llc Compositions and methods for high efficiency protein precipitation

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4540573A (en) * 1983-07-14 1985-09-10 New York Blood Center, Inc. Undenatured virus-free biologically active protein derivatives
US4764369A (en) * 1983-07-14 1988-08-16 New York Blood Center Inc. Undenatured virus-free biologically active protein derivatives
US4820805A (en) * 1983-07-14 1989-04-11 New York Blood Center, Inc. Undenatured virus-free trialkyl phosphate treated biologically active protein derivatives
US4684723A (en) * 1985-09-11 1987-08-04 Miles Laboratories, Inc. Method of separating proteins from aqueous solutions
US4789545A (en) * 1986-03-31 1988-12-06 New York Blood Center, Inc. Removal of lipid soluble process chemicals from biological materials by extraction with naturally occurring oils or synthetic substitutes thereof
ATE85221T1 (de) * 1988-11-05 1993-02-15 Octapharma Ag Verfahren zur herstellung eines hochreinen, nicht infektioesen antihaemophiliefaktors mittels chromatographie.
US5395923A (en) * 1993-02-23 1995-03-07 Haemacure-Biotech, Inc. Process for the obtention of a biological adhesive made of concentrated coagulation factors by "salting-out"

Also Published As

Publication number Publication date
CA2161804C (en) 2003-12-02
NO313084B1 (no) 2002-08-12
ES2164702T3 (es) 2002-03-01
AU677332B2 (en) 1997-04-17
JP3771935B2 (ja) 2006-05-10
CA2161804A1 (en) 1994-11-24
DE69428356T2 (de) 2002-04-25
SE9301582D0 (sv) 1993-05-07
JPH08509746A (ja) 1996-10-15
FI955306A (fi) 1995-11-06
NO954428L (no) 1995-11-06
PT700300E (pt) 2002-03-28
NZ266234A (en) 1996-06-25
EP0700300B1 (de) 2001-09-19
FI113779B (fi) 2004-06-15
DE69428356D1 (de) 2001-10-25
WO1994026287A1 (en) 1994-11-24
FI955306A0 (fi) 1995-11-06
NO954428D0 (no) 1995-11-06
DK0700300T3 (da) 2001-12-31
US5817765A (en) 1998-10-06
EP0700300A1 (de) 1996-03-13
AU6763494A (en) 1994-12-12

Similar Documents

Publication Publication Date Title
ATE205719T1 (de) Reinigung von plasmaproteinen
DK0707594T3 (da) Adskillelse af proteiner
DK0775150T3 (da) Fremgangsmåde til reduktion eller fjernelse af endotoksiner
EE9700200A (et) Bis-aminohappe hüdroksüetüülamino-sulfoonamiidsed retroviirusliku proteaasi inhibiitorid
ATE171189T1 (de) Trennung von proteinen
ATE346088T1 (de) Kristallisierbare zusammensetzungen, die einen komplex von protease-domäne ns3 und ns4a aus dem hepatitis c virus enthalten, und damit bereitgestellte kristalle
EA199700221A1 (ru) Замещенный аминокислотой гидроксиэтиламиносульфонамид в качестве ингибиторов ретровирусной протеазы
ES2139227T3 (es) Concentrado de fibrinogeno obtenido de plasma sanguineo, procedimiento e instalacion para su preparacion.
DE69626976D1 (de) BEHANDLUNG EINER PROTEINLÖSUNG MIT A1/Fe UND ANSCHLIESENDE MEMBRANKONZENTRATION
DE59308628D1 (de) Verfahren zur Herstellung von Faktor VIII
ATE432946T1 (de) Abtrennung von fibrinogen von plasmaproteasen
DE3763601D1 (de) Verfahren zum isolieren und reinigen von haemin.
DE69029471D1 (de) Wiedergewinnungsverfahren von mikrobiell erzeugtem chymosin
DE69820580D1 (de) Verfahren zur Abtrennung von Metallen durch micellare Ultrafiltration, geeignet zur Behandlung von radioaktiven Abfallstoffen
DE69811758D1 (de) Verwendung von Hyaluronsäure zur Herstellung einer wässrigen Lösung verwendbar als intra-artikulare Reinigungslösung
FI1343809T4 (fi) Menetelmä alfa-1 proteinaasinestäjän valmistamiseksi
NO994821L (no) Fremgangsmåte ved inaktivering av patogener, spesielt virus, i et biologisk materiale
DE69426790D1 (de) Verfahren zur Fraktionierung von deacylierten Glycerophospholipiden
ATE103606T1 (de) Verfahren zur herstellung von sulfinylpristinamycin iib.
DE60105760D1 (de) Verfahren zur behandlung von mitteln zur reinigung von abgasen

Legal Events

Date Code Title Description
EEFA Change of the company name
EEIH Change in the person of patent owner